It looks like you already have an account on AdvantageCEUs.com. Login to continue

Physical Therapy for Children- Module 7: Cystic Fibrosis, Asthma, and Cardiothoracic Surgery

Product #
1101PT
Type
PT/PTA
Hours
10
Approval Status

Course Description:

This course was adapted from the textbook: Physical Therapy for Children, 4th Edition.  It provides the essential information needed by PTs, both student and professional, when working with children. Like the previous bestselling editions, the 4th edition follows the practice pattern categories of the Guide to Physical Therapist Practice and uses the IFC model of the disabling process as it presents up-to-date evidence-based coverage of treatment. In this latest edition, Suzann Campbell DeLapp, PT, PhD, FAPTA, Robert J. Palisano, PT, ScD and Margo N. Orlin, PT, PhD, have added more case studies and video clips, additional chapters and Medline-linked references online, and Evidence to Practiceboxes to make it easy to find and remember important information. 

Module 7: Cystic Fibrosis, Asthma, and Cardiothoracic surgery covers chapters 24, 25, and 26.

  • Chapter 24: Cystic Fibrosis
  • Chapter 25: Asthma: Multisystem Implications
  • Chapter 26: Thoracic Surgery 

Methods of Instruction:

Online course available via internet 

Target Audience:

Physical Therapists, Physical Therapist Assistants and Athletic Trainers. 

Educational Level:

Intermediate 

Prerequisites:

None 

Course Goals and Objectives:

At the completion of this course, participants should be able to:

1.  Recognize the incidence, prevalence and etiology of Cystic Fibrosis
2.  Recognize the current medical management of Cystic Fibrosis
3.  Identify the primary physiologic abnormalities of Cystic Fibrosis
4.  Recognize common CF signs and symptoms
5.  Recognize the current physical therapy examination tools to measure function and activity in patients with CF
6.  Identify alternative methods for mobilizing secretions in patients with CF
7.  Recognize current management of body functions and structures in patients with CF
8.  Recognize the pathophysiology characteristics of Asthma
9.  Differentiate between the Steps using the Clinical Classification of the Disease Severity of Asthma
10.  Recognize current medical management of Asthma
11.  Recognize possible side effects of Asthma medications
12.  Identify the incidence of congenital heart defects
13.  Differentiate between acyanotic defects
14.  Identify the most common congential heart defect
15.  Differentiate between cyantoic defects
16.  Differentiate between types of defects and their common physical therapy issues
17.  Recognize the goals of pulmonary management
18.  Identify the postsurgical neurologic implications and complications
19.  Recognize age-specific disabilities in the immediate postoperative period
20.  Identify current postsurgical physical therapy interventions 

Criteria for Obtaining Continuing Education Credits:

A score of 70% or greater on the post-test

PT State Approvals

Alabama
Board Accepted/Approved
Alaska
Approved
Arizona
Approved Category A
Arkansas
Arkansas PT Board Approved
California
Approved
Colorado
Approved- Meets CO DORA for Category 1
Connecticut
Board Accepted/Approved
Delaware
Approved
District of Columbia
Approved
Florida
Florida Approved for Online/Home Study
Georgia
Approved
Hawaii
Approved
Illinois
Illinois Approved Provider (#216.000250)
Indiana
Approved-Category 1
Iowa
Board Accepted/Approved
Kansas
Board Accepted/Approved
Maine
No State Requirements
Massachusetts
Approved
Michigan
Approved (Activity Code 1)
Mississippi
Approved
Missouri
Approved
Montana
Approved Category A
Nebraska
Board Accepted/Approved
New Hampshire
Board Accepted/Approved
New York
Approved Provider
North Carolina
Approved
North Dakota
Board Accepted/Approved
Oklahoma
Approved- Oklahoma Medical Board Via CE Broker
Oregon
Approved
Pennsylvania
Approved - (10GEN, 0DA)
Rhode Island
Approved
South Carolina
Board Accepted/Approved
South Dakota
No State Requirements
Tennessee
Board Accepted/Approved-Class 1
Texas
TPTA Approved/Accredited Provider # 2501036TX
Utah
Board Accepted/Approved
Vermont
Approved
Virginia
Approved-Type 1
Washington
Board Accepted/Approved
Wisconsin
Approved
Wyoming
Board Accepted/Approved